<< Genzyme's Lumizyme for Pompe disease receives FDA marketing approval | Mylan Pharmaceuticals introduces Temazepam Capsules USP, 7.5 mg >>
Read in | English | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | Ελληνικά | हिन्दी | Русский | Polski

Research and Markets offers report on global markets for HIV drugs

Published on May 25, 2010 at 12:24 PM · No Comments

Research and Markets (http://www.researchandmarkets.com/research/e6a885/hiv_drugs_global) has announced the addition of the "HIV Drugs - Global Strategic Business Report" report to their offering.

“HIV Drugs - Global Strategic Business Report”

This report analyzes the Worldwide markets for HIV Drugs in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 52 companies including Abbott Laboratories, Boehringer Ingelheim GmbH , Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Koronis Pharmaceuticals, Inc., Merck & Co., Inc., Pfizer, Inc., Tibotec BVBA, ViiV Healthcare, and VIRxSYS Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Key Topics Covered:

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading